Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX6 in Recurrent or Metastatic Esophageal Cancer
NCT01605305Phase 2Completed
- Sponsor
- Fudan University
- Start
- Sep 2008
- Primary completion
- Jan 2012
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
A Phase 2 trial of oxaliplatin, folinic acid, fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Started Sep 2008; status: completed.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01605305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605305.